{
    "clinical_study": {
        "@rank": "163146", 
        "acronym": "ROPI-LEVO", 
        "arm_group": [
            {
                "arm_group_label": "ropivaca\u00efne 0,5%,", 
                "arm_group_type": "Active Comparator", 
                "description": "intrathecal administration of 15mg of ropivacaine 0.5%."
            }, 
            {
                "arm_group_label": "l\u00e9vobupivaca\u00efne 0,5%", 
                "arm_group_type": "Active Comparator", 
                "description": "intrathecal administration of 15mg of levobupivacaine 0.5%"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a Biomedical Research, prospective, randomized, double blind, controlled\n      monocentric, phase IV comparison of the effects of two local anesthetics intrathecally: 0.5%\n      levobupivacaine and ropivacaine 0.5%."
        }, 
        "brief_title": "Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients Undergoing Lower Limb Surgery", 
        "detailed_description": {
            "textblock": "Progress in the practice of anesthesia led to a safety requirement of growing in daily\n      practice. Spinal anesthesia commonly used technique for surgery of the lower limbs, provides\n      a triple neurological lock (sensory, motor and autonomic) of roots of the spinal cord by\n      intrathecal injection of a local anesthetic agent, following the rules of and strict aseptic\n      conditions.\n\n      Levobupivacaine and ropivacaine local anesthetic agents are considered less toxic and tend\n      to replace the use of bupivacaine, reference molecule, but the plasma transition is\n      extremely toxic to patients. However, there is currently no study comparing the benefits of\n      levobupivacaine and ropivacaine in isobaric form injected intrathecally for trauma surgery\n      of the lower limbs. We propose to conduct a prospective, randomized double-blind comparison\n      of the use of these two molecules in spinal isobaric form by evaluating the time and\n      duration of action (sensory and motor block), hemodynamic and ventilatory changes\n      (sympathetic block), and the occurrence of any adverse events."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient admitted to the emergency for lower limb trauma,\n\n          -  age over 18 years and below 65 years\n\n          -  lower limb trauma surgery can be performed under spinal anesthesia.\n\n        Exclusion Criteria:\n\n          -  Refusal of patients to participate in the study,\n\n          -  Patient with cons-indication to spinal anesthesia:\n\n               -  Local anesthetic allergy agents (1/13000)\n\n               -  bleeding disorders, including pharmacological origin\n\n               -  infection at the puncture site,\n\n               -  refusal of spinal anesthesia by the patient,\n\n          -  Patient trust,\n\n          -  Patients whose coagulation is abnormal.\n\n          -  Patients with cognitive impairment or incapacitated adult,\n\n          -  Multiple trauma,\n\n          -  Porphyria,\n\n          -  Central preexisting neuropathy,\n\n          -  A history of spinal surgery,\n\n          -  Epilepsy uncontrolled by treatment,\n\n          -  Hypovolemia,\n\n          -  Pregnant or lactating women,\n\n          -  Participation in another ongoing clinical trial,\n\n          -  Patient on anticoagulant therapy,\n\n          -  Patient not affiliated with a social security system."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01935596", 
            "org_study_id": "PI09 - Pr. DUPONT/LAIGLE"
        }, 
        "intervention": [
            {
                "arm_group_label": "ropivaca\u00efne 0,5%,", 
                "description": "spinal anesthesia.", 
                "intervention_name": "ropivaca\u00efne", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "l\u00e9vobupivaca\u00efne 0,5%", 
                "intervention_name": "l\u00e9vobupivaca\u00efne", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Ropivacaine", 
                "Levobupivacaine", 
                "Bupivacaine", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anesthesia", 
            "Randomized study", 
            "Lower limbs surgery"
        ], 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "dupont.herv\u00e9@chu-amiens.fr", 
                "last_name": "Herv\u00e9 DUPONT, Professor", 
                "phone": "+333 226 683 75"
            }, 
            "contact_backup": {
                "email": "dupont.herv\u00e9@chu-amiens.fr", 
                "last_name": "christophe LAIGLE, Doctor", 
                "phone": "+333 226 683 75"
            }, 
            "facility": {
                "address": {
                    "city": "Amiens", 
                    "country": "France", 
                    "state": "Picardie", 
                    "zip": "80054"
                }, 
                "name": "Herv\u00e9 DUPONT"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%", 
        "overall_contact": {
            "email": "dupont.herv\u00e9@chu-amiens.fr", 
            "last_name": "Herv\u00e9 DUPONT, Professor", 
            "phone": "+333 226 683 75"
        }, 
        "overall_contact_backup": {
            "email": "laigle.christophe@chu-amiens.fr", 
            "last_name": "Christophe LAIGLE, Doctor"
        }, 
        "overall_official": {
            "affiliation": "CHU Amiens France", 
            "last_name": "Herv\u00e9 DUPONT, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "FRANCE : Agence National de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (Saint Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Thermo-algesic exploration of sensitivity through the application of an ice cube", 
            "measure": "duration of anesthesia on sensitivity", 
            "safety_issue": "No", 
            "time_frame": "during 6h after induction"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01935596"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Duration of anesthesia on motor block", 
            "safety_issue": "No", 
            "time_frame": "during 6h after induction"
        }, 
        "source": "Centre Hospitalier Universitaire, Amiens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire, Amiens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}